eMed Population Health Appoints Renowned Industry Leader Amy Elkins as Chief Operating Officer Français

MIAMI, Sept. 8, 2025 /PRNewswire/ -- eMed Population Health, Inc. today announced the appointment of Amy Elkins as Chief Operating Officer. A seasoned executive, Elkins will lead eMed's operational strategy and execution across enterprise solutions, with a focus on scaling the company's GLP-1 and preemptive care platform for employers and payers worldwide.

In her role, Elkins will oversee eMed's global operations, including marketing, product, member experience, value extensions and partner delivery. She will also spearhead eMed's GLP-1 population health platform with broader preemptive care capabilities – advancing the company's mission to transform how diabetes, hypertension, and heart disease are prevented and managed. Her appointment builds on recent strategic investment from Aon and corporate collaborations with global leaders.

"Amy is a true innovator," said eMed Population Health CEO Linda Yaccarino. "She has a rare ability to identify transformational opportunities, lead with purpose, and scale organizations with measurable impact. Her commitment to health equity and operational excellence makes her the ideal leader to guide eMed's next phase of growth."

The World Obesity Federation's 2023 report forecasts over 51% of the world's population will be overweight or obese by 2035, totaling approximately 4 billion people. The economic impact is expected to reach $4.32 trillion annually by 2035. Demand for GLP-1 has surged, rising more than 300% in the past two years, highlighting the urgency for solutions that improve adherence, retention and clinical outcomes while managing employer and payer costs.

"eMed is redefining what's possible by leveraging cutting edge medication, technology and support. eMed's approach addresses health concerns so many of us are facing," Elkins said. "We are creating a future with defining impact. eMed is tailored to help people live healthier lives while reducing the cost of care for families, employers, and health systems."

Elkins is an award-winning marketer that brings extensive experience in global leadership and strategy. In her previous roles, she served as X's Global Head of Strategic Partnerships, President of Marketing at STX Entertainment and held various executive posts at Mindshare, Metro-Goldwyn-Mayer and MEC. Elkins is also a member of the Academy of Motion Picture Arts and Sciences and a graduate of UCLA.

eMed is transforming population health with an integrated, digital-first platform that unites at-home diagnostics, proctor-led screenings, physician-directed prescribing, and ongoing adherence support. The platform is being adopted globally by employers and payers, establishing a new standard for employee health benefits and public health programs. By expanding its provider network, data intelligence, and behavioral health capabilities, eMed is poised to drive measurable outcomes and lasting impact across populations.

About eMed
eMed is the world's first end-to-end GLP-1 care platform built on Empathetic AI™. From remote diagnostics and clinician-led prescriptions to adherence coaching and insights, eMed empowers employers to manage population health with accountability and compassion. Learn more at www.eMed.com.

SOURCE eMed